Differential T-cell and antibody responses induced by mRNA versus adenoviral vectored COVID-19 vaccines in patients with immunodeficiencies

BACKGROUND: Immunodeficient patients (IDPs) are at higher risk of contracting severe coronavirus disease 2019 (COVID-19). Targeted vaccination strategies have been implemented to enhance vaccine-induced protection. In this population, however, clinical effectiveness is variable and the duration of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguinam, Ernest T., Nadesalingam, Angalee, Chan, Andrew, Smith, Peter, Paloniemi, Minna, Cantoni, Diego, Gronlund, Jessica, Gronlund, Helen, Carnell, George W., Castillo-Olivares, Javier, Temperton, Nigel, Blacklaws, Barbara, Heeney, Jonathan L., Baxendale, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015741/
https://www.ncbi.nlm.nih.gov/pubmed/37038555
http://dx.doi.org/10.1016/j.jacig.2023.100091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015741/
https://www.ncbi.nlm.nih.gov/pubmed/37038555
http://dx.doi.org/10.1016/j.jacig.2023.100091

Ejemplares similares